Sanofi

We chase the miracles of science so you can chase your dreams.

Srini Rao, wearing a white Sanofi lab coat, examines a sample using a microscope in a laboratory filled with scientific equipment.

From Roadside Discovery to Revolutionary Science

From a childhood encounter with a worn science book in Bangalore to leading Sanofi's cutting-edge research platforms, Srini Rao's journey embodies the transformative power of discovery. Now he's at the forefront of Sanofi's AI-powered revolution, driving innovations that turn laboratory breakthroughs into life-changing treatments for patients worldwide.

3D rendering of a purple and gray influenza virus particle on a gradient purple background, with the word ‘Flunomics’ in white and purple text to the right

Flunomics: Assessing the True Impact of Flu

Sanofi’s Flunomics reveals the hidden impact of the 2024/2025 flu season on health systems and defines what effective protection should look like.

Man and woman smiling, holding a dog and posing with a cow

Becky's cGVHD Journey: A Story of Resilience and Hope

Becky Dame received a life-changing leukemia diagnosis in college that led to her developing chronic graft-versus-host-disease. Through the highs and lows of her difficult health journey, Becky leaned on her loved ones for support. Determined to give back, she transformed her health challenges into a calling to help others living with chronic disease. Check out her inspiring story.

Latest News


November 7, 2025
ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review

November 4, 2025
ASH: new data reinforce Sanofi’s leadership in rare diseases and blood cancers

October 22, 2025
Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study

Explore More

Julia Schwendner, dressed in personal protective equipment, works on the manufacturing floor.

Third Quarter 2025 Results

October 24, 2025

Third quarter 2025 results were reviewed by management during a live audio webcast with the financial community.

Sanofi’s 2025 Pricing Principles Report

Sanofi’s 2025 Pricing Principles Report underscores our commitment to fostering a culture of transparency in the healthcare system and advocating for policies that make our treatments accessible and affordable to those in need.

A Million Conversations

People need healthcare systems – at all levels – to better reflect society. So we must listen to marginalized communities more and use those insights to help the healthcare industry, policymakers and governments to fix the causes of these trust gaps.

Pursue Progress. Discover Extraordinary. 

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

MAT-US-2014105-v8.0-01/2024